EyePoint Pharmaceuticals, Inc. Business Finance Contracts & Agreements
41 Contracts & Agreements
- Credit Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (6)
- Purchase Agreements (3)
- Registration Rights Agreements (2)
- Release Agreements (1)
- Servicing Agreements (1)
- Share Agreements (4)
- Stock Agreements (10)
- Underwriting Agreements (8)
- Warrant Agreements (4)
- Underwriting Agreement, dated October 29, 2024, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (Filed With SEC on October 31, 2024)
- EyePoint Pharmaceuticals, Inc. Amendment No 2. to 2019 Employee Stock Purchase Plan (Filed With SEC on June 21, 2024)
- Form of Stock Option Award for Inducement Grants to executive officer pursuant to the 2023 LTIP (Filed With SEC on March 8, 2024)
- Underwriting Agreement, dated December 4, 2023, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (Filed With SEC on December 8, 2023)
- First Amendment to Loan and Security Agreement, dated June 2, 2022, by and among EyePoint Pharmaceuticals, Inc., EyePoint Pharmaceuticals US, Inc., Icon Bioscience, Inc. and... (Filed With SEC on August 5, 2022)
- Loan and Security Agreement, dated March 9, 2022, among EyePoint Pharmaceuticals, Inc., EyePoint Pharmaceuticals US, Inc., Icon Bioscience, Inc. and Silicon Valley Bank (Filed With SEC on March 14, 2022)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on November 19, 2021)
- Underwriting Agreement, dated November 16, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on November 19, 2021)
- EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan, as amended (Filed With SEC on June 24, 2021)
- Amendment No. 3 and Waiver To Term Loan Agreement, dated May 3, 2021, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,... (Filed With SEC on May 5, 2021)
- Royalty Purchase Agreement, dated December 17, 2020, by and between EyePoint Pharmaceuticals, Inc. and SWK Funding, LLC (Filed With SEC on March 12, 2021)
- First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on February 3, 2021)
- Underwriting Agreement, dated February 1, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on February 3, 2021)
- Voting and Investor Rights Agreement, dated December 31, 2020, by and among EyePoint Pharmaceuticals, Inc., Ocumension Therapeutics, and EW Healthcare Partners, L.P. and EW... (Filed With SEC on January 4, 2021)
- Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on January 4, 2021)
- Amendment No. 2 and Waiver To Term Loan Agreement, dated October 8, 2020, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,... (Filed With SEC on October 8, 2020)
- Underwriting Agreement, dated February 21, 2020, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on February 24, 2020)
- Waiver To Term Loan Agreement, dated November 19, 2019, among EyePoint Pharmaceuticals, as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as subsidiary... (Filed With SEC on November 22, 2019)
- EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on June 28, 2019)
- Underwriting Agreement, dated March 28, 2019, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on April 1, 2019)
- Term Loan Agreement, dated February 13, 2019, among EyePoint Pharmaceuticals, Inc., as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as Subsidiary... (Filed With SEC on February 19, 2019)
- Fee Letter, dated February 13, 2019, by and between EyePoint Pharmaceuticals, Inc. and CRG Servicing LLC (Filed With SEC on February 19, 2019)
- Stock Option Award Agreement, dated August 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and John Weet (Filed With SEC on November 9, 2018)
- Stock Option Award Agreement, dated August 1, 2018, by and between EyePoint Pharmaceuticals, Inc. and David Price (Filed With SEC on November 9, 2018)
- Stock Option Award Agreement, dated May 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and Leonard M. Blum (Filed With SEC on November 9, 2018)
- Stock Option Award Agreement, dated May 14, 2018, by and between EyePoint Pharmaceuticals, Inc. and Leonard M. Blum (Filed With SEC on November 9, 2018)
- Form of Stock Option Award Agreement for Inducement grants to executive officers (Filed With SEC on September 18, 2018)
- Second Registration Rights Agreement, dated as of June 25, 2018, by and among EyePoint Pharmaceuticals, Inc. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P.... (Filed With SEC on June 27, 2018)
- Form of Warrant to Purchase Common Stock of EyePoint Pharmaceuticals, Inc., issued June 25, 2018, to the Second Tranche Investors (Filed With SEC on June 27, 2018)
- Credit Agreement, dated as of March 28, 2018, among pSivida Corp., SWK Funding LLC and the financial institutions party thereto from time to time as lenders (Filed With SEC on March 29, 2018)
- Registration Rights Agreement, dated as of March 28, 2018, by and among pSivida Corp. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P (Filed With SEC on March 29, 2018)
- Second Securities Purchase Agreement, dated as of March 28, 2018, by and among pSivida Corp. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P. and each other... (Filed With SEC on March 29, 2018)
- Securities Purchase Agreement, dated as of March 28, 2018, by and among pSivida Corp. and EW Healthcare Partners, L.P. and EW Healthcare Partners-A, L.P (Filed With SEC on March 29, 2018)
- Warrant to Purchase Common Stock of pSivida Corp., issued March 28, 2018, to SWK Funding LLC (Filed With SEC on March 29, 2018)
- PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on February 8, 2017)
- Nonstatutory Stock Option Inducement Award (Filed With SEC on November 8, 2016)
- PSIVIDA CORP. 4,000,000Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 8, 2016)
- PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on December 20, 2013)
- PSIVIDA CORP. 3,494,550 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 19, 2013)
- COMMON STOCK PURCHASE WARRANT PSIVIDA CORP. (Filed With SEC on August 2, 2012)
